For more information, please contact The Ahearne Law Firm, PLLC for an initial consultation and case evaluation. Call nationwide at (845) 986-2777.
The following is the status of pending multidistrict litigation (MDL) and defective product recalls by major orthopedic medical device manufacturer, Zimmer Biomet:
2391 IN RE: Biomet M2a Magnum Hip Implant Products Liability Litigation
Northern District of Indiana (Hon. Robert L. Miller)
Judge Miller recently denied Biomet’s motions for summary judgment related to (i) the Taper, ReCap, and metal-on-polyethylene devices included in the MDL, and (ii) “state-of-the-art” defenses.
A settlement program between was announced in early 2014 in which certain patients implanted with Zimmer Biomet’s defective M2a Magnum hip implant system were to receive up to $200,000. In December, the Court activated a pool of lawsuits as “Group 5” for case-specific discovery. Pursuant to the Court’s order, (i) completed and updated medical records authorizations for the Group 5 cases were to be provided by February 2, 2018, and (ii) the parties may engage in case-specific discovery relating to the Group 5 cases until September 14, 2018. Such discovery may include interrogatories, requests for production, requests for admission, and depositions of (a) the plaintiffs, (b) the implanting surgeon, (c) the revising surgeon, (d) the Zimmer Biomet representative who processed the request for the product used during the implant surgery, (e) any separate Zimmer Biomet representatives who were present in the operating room during the implant or revision surgery, and (f) one additional fact witness per side.
2272 IN RE: Zimmer NexGen Knee Implant Products Liability Litigation
Northern District of Illinois (Hon. Rebecca R. Pallmeyer)
According to a recent case management order, the parties have reached a confidential settlement in principle that will potentially resolve all of the cases on the docket. Judge Pallmeyer stayed all consolidated proceedings in the MDL, as well as any proceedings in individual cases in the MDL, including those selected for trial, pending the outcome and administration of the settlement.
In late January 2017, Zimmer won its third bellwether trial. In the first bellwether trial in November 2015, the jury found for Zimmer given that the plaintiff failed to prove defective design and failure to warn claims. Zimmer also won its second bellwether trial in late 2016 on summary judgment when the judge found that the plaintiff failed to prove that a design defect caused the knee implant to fail.
2158 IN RE: Zimmer Durom Hip Cup Products Liability Litigation
District of New Jersey (Hon. Susan D. Wigenton)
In 2016, Zimmer Inc. reached a $314 million binding settlement agreement to resolve claims of patients who underwent revision surgery for a Durom Acetabular Component hip (Durom Cup). Only plaintiffs who had “qualified revision surgery” less than nine years after the date of implantation would be eligible for either a base award of $175,000 subject to enhancement or reduction, or a fixed award of $25,000. The May 2016 MDL court order required that all plaintiffs were required to participate in the settlement process. Those who rejected the offer were required to enter mediation, with a deadline of February 28, 2017 to schedule mediation, and have to wait until the settlement process was complete before taking further legal actions. As of January 2018, there were 257 lawsuits still pending in the MDL.
Zimmer Biomet Comprehensive Reverse Shoulder System Humeral Tray Model 115340
In February 2017, the United States Food & Drug Administration (FDA) released information on a Class 1 recall of Zimmer Biomet‘s Comprehensive Reverse Shoulder System. A Class 1 recall is issued when there is “a reasonable probability that use of these products will cause serious adverse health consequences or death.” Zimmer Biomet’s Comprehensive Reverse Shoulder system is a shoulder replacement device designed to be surgically implanted to restore arm movement in patients with rotator cuff tears who have developed arthropathy and have failed shoulder joint replacements. The reverse shoulder systems were found to have a higher fracture rate than what was indicated on the product’s label, the FDA stated. These fractures would often require patients to undergo revision surgeries, which could cause more damage, including permanent loss of their shoulder function, infection from the implantation surgery, or death. Zimmer Biomet recalled a total of 3,662 devices with product codes KWS and PAO and all lots with part number 115340 manufactured between August 25, 2008 and September 27, 2011, and distributed between October 2008 and September 2015. On December 20, 2016, Zimmer Biomet started sending recall notices for the reverse total shoulder implants and informed the medical community how to quarantine and return the devices affected by the recall.
Other Zimmer Biomet News
Zimmer Biomet reported $7.82 billion in full-year 2017 sales, a 1.8% increase over 2016. Net earnings for the full year grew to $1.8 billion. Fourth quarter sales topped $2 billion, an increase of 3% from Q4 2016. Zimmer Biomet’s fourth quarter net earnings were $1.25 billion. Zimmer Biomet anticipates revenues in the first quarter of 2018 between $1.95 billion and $1.99 billion.
#zimmer #biomet #hip #knee #shoulder #implant #recall #lawsuit #productliability
If you or a family member have suffered injury from an orthopedic medical device such as a hip, knee or shoulder implant, or have had revision surgery to remove and replace a hip, knee or shoulder implant, you and/or your family member may be entitled to money damages.
We take your calls and meet with your family personally to answer all your questions. We will press your insurance company for the coverage you are entitled to and help you recover the compensation you deserve. Personal injury cases require a wealth of experience, and a network of proven experts, including doctors and medical experts, accident recreation experts, insurance investigators, private investigators, and the resources necessary to fight large insurance companies.
All of our personal injury cases are contingency cases, which means you pay nothing out of pocket and we do not get paid unless you get paid.